- Home
- Contact Us
- Home
- Solutions
- By Diseases
- Nerve Cancer
- Blood Cancer
- Myeloid Proliferations and Neoplasms
- Histiocytic and Dendritic Cell Neoplasms
- B-cell Lymphoid Proliferations and Lymphomas
- B-cell Lymphoma (BCL)
- Chronic Lymphocytic Leukemia (CLL)
- Hairy Cell Leukemia (HCL)
- Waldenström Macroglobulinaemia (WM)
- Marginal Zone Lymphoma (MZL)
- Mucosa-associated Lymphoid Tissue Lymphoma (MALT)
- Follicular Lymphoma (FL)
- Mantle Cell Lymphoma (MCL)
- Diffuse Large B-cell Lymphoma (DLBCL)
- Grey Zone Lymphoma (GZL)
- Primary Central Nervous System Lymphoma (PCNSL)
- Burkitt Lymphoma (BL)
- Hodgkin's Lymphoma (HL)
- Multiple Myeloma (MM)
- B-cell Lymphoma (BCL)
- T-cell and NK-cell Lymphoid Proliferations and Lymphomas
- Stroma-derived Neoplasms of Lymphoid Tissues
- Genetic Tumor Syndromes
- Leukemia Animal Model Development Services
- Lung Cancer
- Adenosquamous Carcinoma of the Lung (ASC)
- Large Cell Neuroendocrine Carcinoma of the Lung (LCNEC)
- Salivary Gland-type Carcinoma of the Lung (SGTTL)
- Sarcomatoid Carcinoma of the Lung (SCL)
- Granular Cell Tumor (GCT) of the Lung
- Pancoast Tumors
- Bronchoalveolar Carcinoma (BAC)
- Small Cell Lung Cancer (SCLC)
- Pulmonary Adenoid Cystic Carcinoma (PACC)
- Pleuropulmonary Blastoma (PPB)
- Asbestosis
- Pulmonary Lymphomas
- Pharyngeal Cancer
- Mucous Gland Adenoma of the Lung
- Pulmonary Sarcomas
- Pulmonary Hamartomas (PHs)
- Digestive Cancer
- Anal Lymphoma
- Anal Sarcoma
- Anal Transitional Cell Carcinoma (ATCC)
- Anal Verrucous Carcinoma (AVC)
- Colon Neuroendocrine Tumor
- Extrahepatic Cholangiocarcinoma (eCCA)
- Gallbladder Neuroendocrine Carcinoma (GB-NEC)
- Gastrointestinal Carcinoid Tumor
- Gastrointestinal Stromal Tumor (GIST)
- Klatskin Tumor
- Malignant Peritoneal Mesothelioma (MPM)
- Multifocal Intrahepatic Cholangiocarcinoma (ICC)
- Peritoneal Carcinomatosis
- Pseudomyxoma Peritonei (PMP)
- Esophageal Cancer (ESCR)
- Gastric Cancer (GASC)
- Colorectal Cancer (CRC)
- Pancreatic Cancer (PNCA)
- Hepatocellular Carcinoma (HCC)
- Cholangiocarcinoma (CCA)
- Anal Squamous Cell Carcinoma (ASCC)
- Anal Adenocarcinoma
- Anal Canal Neuroendocrine Carcinoma (ANEC)
- Small Intestine Cancer
- Colon Adenocarcinoma (CAC)
- Rectal Adenocarcinoma
- Colorectal Signet Ring Cell Carcinoma (CSRCC)
- Colorectal Lymphoma
- Appendiceal Carcinoma (AC)
- Carcinoma of the Ampulla of Vater (CAV)
- Duodenal Adenocarcinoma (DA)
- Meckel's Diverticulum Carcinoma (MDC)
- Jejunal Adenocarcinoma (JA)
- Fibrolamellar Carcinoma (FLC)
- Primary Hepatic Angiosarcoma (PHA)
- Hepatoblastoma (HB)
- Reproductive System Cancer
- Fallopian Tube Cancer (FTC)
- Ovarian Cancer (OC)
- Uterine Cancer (UC)
- Vulvar Cancer (VC)
- Testicular Cancer (TC)
- Penile Cancer (PC)
- Uterine Sarcoma (US)
- Ovarian Germ Cell Tumor (OGCT)
- Ovarian Sex Cord-Stromal Tumor (OSCST)
- Epithelial Ovarian Cancer (EOC)
- Cervical Adenocarcinoma (CADC)
- Endometrial Clear Cell Carcinoma (ECC)
- Uterine Serous Carcinoma (USC)
- Ovarian Mucinous Carcinoma (MOC)
- Ovarian Granulosa Cell Tumor (OGCT)
- Ovarian Teratoma
- Prostatic Adenocarcinoma (PaC)
- Testicular Seminoma
- Testicular Nonseminoma
- Testicular Embryonal Carcinoma
- Testicular Choriocarcinoma
- Penile Melanoma (PM)
- Prostate Sarcoma
- Penile Leiomyosarcoma
- Penile Squamous Cell Carcinoma (PSCC)
- Testicular Angiosarcoma
- Prostate Leiomyosarcoma
- Urinary System Cancer
- Renal Cell Carcinoma (RCC)
- Bladder Cancer (BLC)
- Urothelial Carcinoma (UC)
- Prostate Cancer (PC)
- Clear Cell Renal Cell Carcinoma (CCRCC)
- Urethral Cancer
- Collecting Duct Carcinoma (CDC)
- Renal Medullary Carcinoma (RMC)
- MiT Family Translocation Renal Cell Carcinomas (tRCC)
- Succinate Dehydrogenase Deficient Renal Cell Carcinoma
- Mucinous Tubular and Spindle Cell Carcinoma (MTSCC)
- Metanephric Adenoma (MA)
- Metanephric Adenofibroma (MAF)
- Metanephric Stromal Tumor (MST)
- Adult Cystic Nephroma (CN)
- Mixed Epithelial and Stroma Tumor (MEST)
- Nephroblastoma
- Renal Mesenchymal Tumors (RMTs)
- Nephrogenic Rests and Nephroblastomatosis
- Congenital Mesoblastic Nephroma (CMN)
- Clear Cell Sarcoma of the Kidney (CCSK)
- Rhabdoid Tumor of Kidney (RTK)
- Ossifying Renal Tumor of Infancy (ORTI)
- Papillary Renal Cell Carcinoma (pRCC)
- Chromophobe Renal Cell Carcinoma (chRCC)
- Renal Oncocytoma (RO)
- Renal Pelvic Squamous Cell Carcinoma
- Renal Pelvis Transitional Cell Carcinoma (TCC)
- Urethral Neuroendocrine Tumor (UNET)
- Sarcoma
- Breast Cancer (BC)
- Sporadic Breast Cancer (SBC)
- Bilateral Breast Cancer (BBC)
- Triple-Negative Breast Cancer (TNBC)
- Invasive Ductal Carcinoma (IDC)
- Invasive Lobular Carcinoma (ILC)
- Ductal Carcinoma in Situ (DCIS)
- Inflammatory Breast Cancer (IBC)
- Mammary Paget Disease (MPD)
- Lobular Carcinoma in Situ (LCIS)
- Breast Phyllodes Tumor
- Metaplastic Breast Cancer (MpBC)
- Tubular Breast Carcinoma
- Mucinous Breast Carcinoma (MBC)
- Papillary Carcinoma of the Breast (PCB)
- Invasive Cribriform Carcinoma (ICC)
- Medullary Breast Carcinoma (MBC)
- Breast Angiosarcoma (BA)
- Neuroendocrine Carcinoma of the Breast (NECB)
- Secretory Carcinoma of the Breast (SCB)
- Adenoid Cystic Carcinoma of the Breast (ACCB)
- Mixed Ductal and Lobular Carcinoma (mDLC)
- Male Breast Cancer (MBC)
- Metastatic Breast Cancer
- Hormone Receptor Positive Breast Cancer
- HER2-Positive Breast Cancer
- Familial Breast Cancer
- BRCA1-associated Breast Cancer
- BRCA2-associated Breast Cancer
- Li-Fraumeni Syndrome (LFS)-associated Breast Cancer
- Cowden Syndrome-associated Breast Cancer
- Skin Cancer
- Acral Lentiginous Melanoma (ALM)
- Cutaneous Squamous Cell Carcinoma (CSCC)
- Basal Cell Carcinoma (BCC)
- Merkel Cell Carcinoma (MCC)
- Dermatofibrosarcoma Protuberans (DFSP)
- Microcystic Adnexal Carcinoma (MAC)
- Sebaceous Carcinoma
- Actinic Keratosis (AK)
- Bowen's Disease (BD)
- Pigmented Basal Cell Carcinoma (PBCC)
- Superficial Spreading Melanoma (SSM)
- Nodular Melanoma (NM)
- Lentigo Maligna Melanoma (LMM)
- Mucosal Melanoma (MM)
- Cutaneous Lymphoma (CL)
- Dedifferentiated Liposarcoma (DDL)
- Atypical Lipomatous Tumors (ALT)
- Myxoid Liposarcoma (MLPS)
- Pleomorphic Liposarcoma (PLPS)
- Cutaneous Hemangioma
- Leiomyosarcoma (LMS)
- Porocarcinoma (PC)
- Trichoepithelioma
- Trichoblastoma
- Dermatofibroma
- Cutaneous Neurofibroma (cNF)
- Cutaneous Sarcoma (CS)
- Malignant Mesothelioma (MM)
- Well-differentiated Papillary Mesothelial Tumor (WDPMT)
- Signet Ring Cell Mesothelioma
- Lymphohistiocytoid Mesothelioma (LHM)
- Myxoid Mesothelioma
- Multicystic Mesothelioma
- Microcystic Mesothelioma
- Localized Malignant Mesothelioma
- Diffuse Malignant Peritoneal Mesothelioma (DMPM)
- Pleural Mesothelioma (PM)
- Primary Pericardial Mesothelioma (PPM)
- Epithelial Mesothelioma (EM)
- Sarcomatoid Mesothelioma (SM)
- Testicular Mesothelioma (TM)
- Biphasic Mesothelioma (BM)
- Retinoblastoma (RB)
- Thyroid Cancer
- Head and Neck Cancer (HNC)
- Nut Midline Carcinoma (NMC)
- Other Cancer
- Craniopharyngioma (CP)
- Lymphatic Malformation (LM)
- Nasopharyngeal Carcinoma (NPC)
- Adenoid Cystic Carcinoma (ACC)
- Mucoepidermoid Carcinoma (MEC)
- Salivary Duct Carcinoma (SDC)
- By Services
- Diagnostics Development Services
- Therapeutics Development Services
- Disease Model Development Services
- Drug Safety Evaluation Services
- Pharmacokinetics Services
- Clinical Research Services
- By Products
- By Diseases
- About Us
- Contact Us
- Careers